Correlation of altered tyrosine phosphorylation with methotrexate resistance in a cisplatin-resistant subline of L1210 cells

Biochemical Pharmacology

Volumn 51, Issue 4, 1996, Pages 477-482

  Bhushan, Alok ^a   Wroblewski, Diana ^a   Xuan, Yongzhi ^a   Tritton, Thomas R ^a   Hacker, Miles P ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

cisplatin; drug resistance; drug transport; L1210 cells; methotrexate; tyrosine phosphorylation

Indexed keywords

CISPLATIN; MEMBRANE PROTEIN; METHOTREXATE; TYROSINE;

ANIMAL CELL; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG MECHANISM; DRUG RESISTANCE; DRUG TRANSPORT; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LEUKEMIA L 1210; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030063931     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)84208-0     Document Type: Article

References (30)

1. Schabel FM Jr, Skipper HE, Trader MW, Laster WR Jr, Griswold DP Jr and Corbett TH, Establishment of cross-resistance profiles for new agents. Cancer Treat Rep 67: 905-922, 1983.
2. Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A and Frei E III, Alkylating agents: In vitro studies of cross-resistance patterns in human cell lines. Cancer Res 46: 4379-4383, 1986.
3. Scanlon KJ, Newman EM, Lu Y and Priest DG, Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923-8925, 1986.
4. Rosowsky A, Wright JE, Cucchi CA, Flatow JL, Trites DH, Teicher BA and Frei E III, Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). Cancer Res 47: 5913-5918, 1987.
5. Wroblewski DH and Hacker MP, The possible role of altered nucleotide metabolism in cisplatin resistance. J Cell Pharmacol 1: 2-7, 1990.
6. Wroblewski DH, Bhushan A, Brinton BT and Hacker MP, Investigations on the mechanisms of methotrexate resistance in a cisplatinum resistant L1210 murine leukemia cell subline. Cancer Chemother Pharmacol, in press.
7. Price EM, Ratnam M, Rodeman KM and Freisheim JH, Characterization of the methotrexate transport pathway in murine L1210 leukemia cells: Involvement of a membrane receptor and cytosolic protein. Biochemistry 27: 7853-7858, 1988.
8. Sirotnak FM, Moccio DM, Kelleher LE and Goutas LJ, Relative frequency and kinetic properties of the transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res 41: 4447-4452, 1981.
9. Henderson GB, Tsuji JM and Kumar HP, Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts. Biochem Pharmacol 36: 3007-3014, 1987.
10. Henderson GB and Tsuji JM, Identification of the bromosulfophthalein-sensitive efflux route for methotrexate as the site of action of vincristine in the vincristine-dependent enhancement of methotrexate uptake in L1210 cells. Cancer Res 48: 5995-6001, 1988.
11. Hunter WM and Greenwood FC, Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495-496, 1962.
12. Price EM and Freisheim JH, Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells. Biochemistry 26: 4757-4763, 1987.
13. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
14. Glenney JR Jr, Zokas L and Kamps MP, Monoclonal antibodies to phosphotyrosine. J Immunol Methods 109: 277-285, 1988.
15. Bradford MM, A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72: 248-254, 1976.
16. Weber K and Osborn M, The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 244: 4406-4412, 1969.
17. Rosowsky A, Wright JE, Cucchi CA, Lippke JA, Tantravahi R, Ervin TJ and Frei E III, Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low level methotrexate resistance. Cancer Res 45: 6205-6212, 1985.
18. Dembo M and Sirotnak FM, Membrane transport of folate compounds in mammalian cells. In: Folate Antagonists as Therapeutic agents (Eds. Sirotnak FM, Burchall JJ, Ensninger WD and Montgomery JA), Vol. 1, pp. 173-183. Academic Press, Orlando, FL, 1984.
19. McCormick JI, Susten SS and Freisheim JH, Characterization of the methotrexate transport defect in a resistant L1210 lymphoma cell line. Arch Biochem Biophys 212: 311-318, 1981.
20. Fan J, Vitols KS and Huennekens FM, Multiple folate transport systems in L1210 cells. Adv Enzyme Regul 32: 3-15, 1992.
21. Freisheim JH, Price EM and Ratnam M, Folate coenzyme and antifolate transport proteins in normal and neoplastic cells. Adv Enzyme Regul 29: 13-26, 1989.
22. Jansen G, Westerhof GR, Kathmann I, Rademaker BC, Rijksen G and Schornagel JH, Identification of a membrane-associated folate binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res 49: 2455-2459, 1989.
23. Freisheim JH, Rathman M and Price EM, Photoaffinity and immunological probes of methotrexate transport proteins in drug sensitive and resistant leukemia cells. Prog Clin Biol Res 292: 453-460, 1989.
24. Henderson GB and Strauss BP, Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells. Cancer Res 50: 1709-1714, 1990.
25. Bernai SD, Speak JA, Boeheim K, Dreyfuss AI, Wright JE, Teicher BA, Rosowsky A, Tsao S-W and Wong Y-C, Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum. Mol Cell Biochem 95: 61-70, 1990.
26. Brigle KE, Westin EH, Houghton MT and Goldman ID, Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. J Biol Chem 266: 17243-17249, 1991.
27. Matherly LH, Czajkowski CA and Angeles SM, Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res 51: 3420-3426, 1991.
28. Matherly LH, Angeles SM and Czajkowski CA, Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. J Biol Chem 67: 23253-23260, 1992.
29. Bishop JM, Cellular oncogenes and retroviruses. Annu Rev Biochem 52: 301-354, 1983.
30. Hanks SK, Quinn AM and Hunter T, The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52, 1988.